GEN Exclusives

More »

GEN News Highlights

More »
Apr 3, 2008

Dr. Reddy’s Makes Its Second Acquisition This Week

  • Dr. Reddy's acquired Jet Generici, a company engaged in the sale of generic finished dosages in Italy. The deal was completed by Reddy Pharma Italia, Dr. Reddy’s subsidiary. 

    This represents Dr. Reddy's second one this week; on April 1, a part of Dow Pharma's small molecule business was bought. Jet Generici will provide access to an essential product portfolio, a pipeline of registration applications, and a sales and marketing organization.

    “Dr. Reddy's has taken a significant step forward by establishing its business in the third largest pharmaceutical market in Europe,” note VS Vasudevan, president and head of European operations for Dr. Reddy’s. "The acquisition has been well timed, since Dr. Reddy's will be able to immediately supplement the Jet Generici portfolio via its own pipeline. We already have registration for one significant Dr. Reddy's product, and a strong pipeline of registration applications."


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »